- Home
- ยป
- Our Product Range
- »
- Anti Cancer Oral Medicines
Anti Cancer Oral Medicines
Tamoxifen Citrate 10 Mg Tablets
| Strength | 10 mg |
| Brand | Tamodex |
| Tablets per Pack | 10 Tablets |
| Usage | Breast Cancer |
| Pack Type | Strip |
| Form | Tablet |
| Manufacturer | Zydus Celexa |
Ninbrosis Nintedanib 100 Tablet
| Brand | Ninbrosis |
| Strength | 100 mg |
| Usage | Lung Cancer |
| Form | Capsule |
| Capsules per Pack | 10 Capsules |
| Pack Type | Blister |
| manufacture | Healing Pharma India Pvt. Ltd. |
Xpreza Azacitidine 200mg Tablet - Vidaza
| Strength | 200 mg |
| Brand | Vidaza Tab |
| Packaging Size | 14 Tablets |
| Form | Tablet |
| Dose Type | Oral |
| Indication | AML |
| Pack Type | Bottle |
| Shelf Life | 24 Months |
Product Name: Xpreza 200mg Tablet
Brand Names: Xpreza, Vidaza, Onureg
Composition: Azacitidine (200mg)
Manufacturer/Marketer: Natco Pharma Ltd
Packaging: To be provided (specify packaging details if available)
Treatment: Myelodysplastic syndromes, chronic myelomonocytic leukemia, acute myeloid leukemia (AML)
Product Description: Xpreza 200mg Tablet contains Azacitidine, a chemotherapy agent used to treat certain blood and bone marrow disorders such as myelodysplastic syndromes and acute myeloid leukemia. It works by restoring normal growth and maturation of blood cells and inhibiting cancerous cell proliferation
Regonat Regorafenib 40mg Tablet - Stivarga
| Strength | 40 mg |
| Composition | Regorafenib |
| Pack Size | 28 Tablets |
| Brand | Regonat |
| Form | Tablet |
| Usage | HCC, GIST |
| Packaging Type | Bottle |
| Country of Origin | India |
Brand Names: Regonat, Stivarga, Regonib
Composition: Regorafenib (40mg)
Manufacturer/Marketer: Natco Pharma Ltd
Packaging: To be provided (specify packaging details if available)
Treatment: Colorectal cancer, gastrointestinal stromal tumors (GIST), hepatocellular carcinoma (HCC)
Product Description: Regonat Tablet contains Regorafenib, a multi-kinase inhibitor used to treat certain types of cancer, including colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma. It works by inhibiting enzymes that promote cancer cell growth and angiogenesis
Megestrol Acetate Oral Suspension ENDACE - Megace
| Strength | 40 mg |
| Brand | Megace |
| Pack Type | Strip |
| Tablets per Pack | 10 Tablets |
| Form | Tablet |
| Usage | Appetite Stimulant |
| Prescription Type | Prescription |
Product Name: ENDACE OS
Brand Name: Endace, Megace, Apetamin
Composition: Megestrol Acetate Oral Suspension USP (40mg/ml)
Manufacturer/Marketer: Samarth Life Sciences
Packaging: To be provided (specify packaging details if available)
Treatment: Appetite stimulation, weight loss management in cancer and AIDS-related cachexia
Product Description: ENDACE OS contains Megestrol Acetate, a synthetic progestin used to stimulate appetite and promote weight gain in patients experiencing severe weight loss due to cancer or AIDS. It works by influencing appetite-regulating hormones and has additional hormonal effects that may be beneficial in certain cancers
Hodpro Procarbazine 50mg Capsule - Matulane
| Strength | 50 mg |
| Pack Size | 50 capsules |
| Brand | Natprocarb |
| Company | Neon Laboratories Ltd |
| Usage | Hodgkin lymphoma |
| Shelf Life | 24 months |
| Form | Capsule |
| Prescription Type | Prescription |
| Country of Origin | India |
Luporal Tegafur Uracil Capsule - Teysuno
| Dose Ratio | 100 mg + 224 mg |
| Capsules per Pack | 10 Capsules |
| Brand | Luporal, Teysuno, Futraful |
| Composition | Tegafur + Uracil |
| Pack Type | Strip |
| Usage | Gastric Cancer, Colorectal Cancer |
| Form | Capsule |
Product Name: Luporal Capsule
Brand Names: Luporal, Teysuno, Futraful
Composition: Tegafur (100mg) + Uracil (224mg)
Manufacturer/Marketer: Lupin Ltd
Packaging: To be provided (specify packaging details if available)
Treatment: Cancer, specifically colorectal and gastric cancer (used as part of chemotherapy)
Product Description: Luporal Capsule contains a combination of Tegafur and Uracil. Tegafur is a prodrug of fluorouracil, which inhibits cancer cell growth, while Uracil enhances the effects of Tegafur by inhibiting its breakdown. This combination is used in the treatment of colorectal and gastric cancers as a chemotherapeutic agent
Ceritinib Spexib 150mg Capsule - Zykadia
| Strength | 150 mg |
| Pack Size | 10 capsules |
| Brand | Zykadia |
| Company | Novartis |
| Usage | NSCLC |
| Shelf Life | 24 months |
| Form | Capsule |
| Prescription Type | Prescription |
| Country of Origin | India |
Product Name: Spexib Capsule
Brand Name: Spexib, Zykadia, Alecensa
Composition: Ceritinib (150mg)
Manufacturer/Marketer: Novartis India Ltd
Packaging: To be provided (specify packaging details if available)
Treatment: Non-small cell lung cancer (NSCLC)
Product Description: Spexib Capsule contains Ceritinib, a tyrosine kinase inhibitor used in the treatment of non-small cell lung cancer (NSCLC) that has a specific mutation (ALK-positive). It works by inhibiting the growth of cancer cells and slowing down the spread of the disease
S One Trio Tegafur Oteracil Gimeracil Capsule - Teysuno
| Dose Ratio | 4.35mg+11.8mg+15mg |
| Capsules per Pack | 7 Capsules |
| Brand | S One, Teysuno, S One Trio |
| Composition | Gimeracil (4.35mg) + Oteracil (11.8mg) + Tegafur (15mg) |
| Pack Type | Strip |
| Usage | Colorectal Cancer, Gastric Cancer |
| Manufacturer | Intas |
| Form | Capsule |
Brand Names: S One, Teysuno, S One Trio
Composition: Gimeracil (4.35mg) + Oteracil (11.8mg) + Tegafur (15mg)
Manufacturer/Marketer: Intas Pharmaceuticals Ltd
Packaging: To be provided (specify packaging details if available)
Treatment: Gastric cancer, colorectal cancer (as part of combination chemotherapy)
Product Description: S One Trio Capsule contains a combination of Gimeracil, Oteracil, and Tegafur, which work together as an oral chemotherapy agent. This medication is primarily used for the treatment of advanced gastric and colorectal cancers, offering a convenient alternative to intravenous chemotherapy
Melphalan Melfalax 2mg Tablet - Evomela
| Strength | 2 mg |
| Packaging Size | 25 tablets |
| Brand | Melfalax |
| Composition | Melphalan |
| Manufacturer | GLS Pharma Ltd |
| Form | Tablet |
| Indication | Ovarian Cancer, Multiple Myeloma |
| Shelf Life | 36 months |
| Country of Origin | India |
Product Name: Melfalax 2mg Tablet
Brand Names: Alkeran, Evomela, Melfalan
Composition: Melphalan (2mg)
Manufacturer/Marketer: GLS Pharma Ltd.
Packaging: To be provided (specify packaging details if available)
Treatment: Multiple myeloma, ovarian cancer, breast cancer
Product Description:
Melfalax 2mg Tablet contains Melphalan, a chemotherapy agent used to treat various types of cancers, including multiple myeloma, ovarian cancer, and breast cancer. It works by interfering with the DNA replication process in cancer cells, thereby slowing their growth and spread
Rahika Capmatinib 200mg Tablet - Tabrecta
| Strength | 200 mg |
| Brand | Capmatinib |
| Packaging Size | 60 Tablets |
| Form | Film Coated Tablet |
| Dose Type | Oral |
| Pack Type | Strip |
| Treatment Type | NSCLC |
| Prescription | Rx Only |
| Shelf Life | 24 Months |
Product Name: Rahika 200mg Tablet
Brand Name: Rahika, Tabrecta, Capmatinib
Composition: Capmatinib (200mg)
Manufacturer/Marketer: Novartis India Ltd
Packaging: To be provided (specify packaging details if available)
Treatment: Non-small cell lung cancer (NSCLC) with MET exon 14 skipping mutations
Product Description: Rahika 200mg Tablet contains Capmatinib, a kinase inhibitor used in the treatment of non-small cell lung cancer (NSCLC) with specific genetic alterations (MET exon 14 skipping mutations). It works by inhibiting the MET receptor pathway, which helps slow or stop cancer cell growth. This medication is prescribed based on genetic testing and under the supervision of an oncologist
Tipanat 8.19mg/20mg Tablet - Lonsurf
| Strength | 20 mg/8.19 mg |
| Brand | Trifluridine Tipiracil |
| Packaging Size | 20 Tablets |
| Form | Tablet |
| Dose Type | Oral |
| Indication | Metastatic CRC, Gastric Cancer |
| Pack Type | Bottle |
| Shelf Life | 24 Months |
Product Name: Tipanat 8.19mg/20mg Tablet
Brand Name: Tipanat, Lonsurf, Trifluridine-Tipiracil
Composition: Tipiracil (8.19mg) + Trifluridine (20mg)
Manufacturer/Marketer: Natco Pharma Ltd
Packaging: To be provided (specify packaging details if available)
Treatment: Metastatic colorectal cancer, metastatic gastric cancer
Product Description: Tipanat 8.19mg/20mg Tablet is a combination of Tipiracil and Trifluridine, used in the treatment of metastatic colorectal and gastric cancers. Trifluridine interferes with cancer cell DNA, while Tipiracil helps maintain its levels, enhancing effectiveness. It is prescribed for patients who have not responded to standard treatments